Goff B A, Muntz H G, Paley P J, Tamimi H K, Koh W J, Greer B E
Department of Obstetrics and Gynecology, University of Washington Medical Center, USA.
Gynecol Oncol. 1999 Sep;74(3):436-42. doi: 10.1006/gyno.1999.5472.
The aim of this study was to evaluate the impact of surgical staging in the treatment and outcome of women with locally advanced cervical cancer.
Ninety-eight women with locally advanced cervical cancer treated between 1993 and 1997 were retrospectively reviewed. Survival probabilities were calculated by the Kaplan-Meier product limit method and compared with the log-rank test.
Of the 98 women treated over the 5-year period, 86 were surgically staged: 61 by a retroperitoneal approach, 18 by laparoscopy, and 7 by laparotomy. Median blood loss was 120 cc and median length of hospitalization was 3 days. Preoperative CT scans (n = 55), when compared with surgical findings, missed macroscopic nodal disease in 20% and microscopic disease in 15% and overcalled disease in 10% of cases. Lymph node metastases were found in 45/86 patients (52%): 12 microscopic and 33 macroscopic. The highest level of nodes found to be involved was pelvic in 23, common iliac nodes in 3, para-aortic nodes in 14, and scalene nodes in 5 cases. Of the 86 patients, 49 received pelvic radiation, 27 received extended field radiation, and 10 were identified for palliative treatment only (5 scalene node metastasis, 5 extensive intraperitoneal disease). For node-negative patients, 5-year survival was 74%; for microscopic nodal involvement it was 58%; and for macroscopic involvement it was 39% (P = 0.007). Five-year survival for women with para-aortic node involvement was 52%. Number of nodes involved was a significant prognostic variable (P = 0.008). Patients who received chemotherapy had a 5-year survival of 68% compared to 35% for those who did not (P = 0.06). Factors which did not affect survival included age, histology, type of surgery, stage, and type of radiation (pelvic vs extended).
Surgical staging of women with locally advanced cervical cancer can be performed with acceptable morbidity and it provided more accurate information than CT scans and resulted in a modification of the standard pelvic radiation field for 43% of our patients. The information obtained from surgical staging allows better individualization of therapy, which may improve overall clinical outcome.
本研究旨在评估手术分期对局部晚期宫颈癌女性患者治疗及预后的影响。
回顾性分析1993年至1997年间接受治疗的98例局部晚期宫颈癌女性患者。采用Kaplan-Meier乘积限法计算生存概率,并通过对数秩检验进行比较。
在这5年期间接受治疗的98例女性患者中,86例行手术分期:61例采用腹膜后途径,18例采用腹腔镜,7例采用剖腹手术。中位失血量为120毫升,中位住院时间为3天。术前CT扫描(n = 55)与手术结果相比,20%的病例漏诊了宏观淋巴结疾病,15%漏诊了微观疾病,10%的病例误诊。86例患者中有45例(52%)发现淋巴结转移:12例为微观转移,33例为宏观转移。发现受累淋巴结的最高水平为盆腔23例,髂总淋巴结3例,腹主动脉旁淋巴结14例,斜角肌淋巴结5例。86例患者中,49例接受盆腔放疗,27例接受扩大野放疗,10例仅确定为姑息治疗(5例斜角肌淋巴结转移,5例广泛腹膜内疾病)。对于淋巴结阴性患者,5年生存率为74%;对于微观淋巴结受累患者,为58%;对于宏观受累患者,为39%(P = 0.007)。腹主动脉旁淋巴结受累女性患者的5年生存率为52%。受累淋巴结数量是一个显著的预后变量(P = 0.008)。接受化疗的患者5年生存率为68%,未接受化疗的患者为35%(P = 0.06)。不影响生存的因素包括年龄、组织学、手术类型、分期和放疗类型(盆腔放疗与扩大野放疗)。
局部晚期宫颈癌女性患者的手术分期可在可接受的发病率下进行,且比CT扫描提供更准确的信息,使43%的患者的标准盆腔放疗野得到修改。从手术分期获得的信息有助于更好地实现个体化治疗,这可能改善总体临床结局。